Application performance monitoring software provider Dynatrace (NYSE:DT) reported Q1 CY2025 results beating Wall Street’s revenue expectations, with sales up 16.9% year on year to $445.2 million. On top of that, next quarter’s revenue guidance ($467.5 million at the midpoint) was surprisingly good and 3% above what analysts were expecting. Its non-GAAP profit of $0.33 per share was 9.1% above analysts’ consensus estimates.
LAM RESEARCH CORP (NASDAQ:LRCX) offers strong growth potential, solid profitability, and reasonable valuation, making it a compelling choice for investors seeking affordable growth in the semiconductor sector.
GLOBUS MEDICAL (NYSE:GMED) offers strong growth potential at a reasonable valuation, backed by solid financial health. A closer look at its fundamentals suggests it could be a compelling pick for growth-oriented investors.
Major cryptocurrencies are slightly up on early Wednesday morning, with Bitcoin holding steady and altcoins like Ethereum, XRP, Dogecoin and Solana pushing higher.
Asia's main stock index increased, driven by the technology sector, as investors anticipated earnings reports from major Chinese tech companies this week.
Federal regulators are pressing Tesla Inc. for details on how its driverless taxis will operate safely in challenging conditions as the electric vehicle maker prepares for a pivotal robotaxi launch in Austin next month.
Beauty and waxing service franchise European Wax Center (NASDAQ:EWCZ) announced better-than-expected revenue in Q1 CY2025, but sales were flat year on year at $51.43 million. The company expects the full year’s revenue to be around $212 million, close to analysts’ estimates. Its GAAP profit of $0.04 per share was $0.02 above analysts’ consensus estimates.
